Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patients.

Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patients.

Optimal vaccine strategies must be identified for improving T-cell vaccination against infectious and malignant diseases. MelQbG10 is a virus-like nano-particle loaded with A-type CpG-oligonucleotides (CpG-ODN) and coupled to peptide(16-35) derived from Melan-A/MART-1. In this phase IIa clinical st...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Goldinger, S, Dummer, R, Baumgaertner, P, Mihic-Probst, D, Schwarz, K, Hammann-Haenni, A, Willers, J, Geldhof, C, Prior, J, Kündig, T, Michielin, O, Bachmann, M, Speiser, D
التنسيق:	Journal article
اللغة:	English
منشور في:	2012

مواد مشابهة

Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients.
حسب: Speiser, D, وآخرون
منشور في: (2010)

TLR9- and TLR7-enhanced CD8(+) T cell responses are suppressed by TLR2-ligands
حسب: Schwarz, K, وآخرون
منشور في: (2007)

The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma.
حسب: Beeh, K, وآخرون
منشور في: (2013)

Virus-like particles induce robust human T-helper cell responses.
حسب: Braun, M, وآخرون
منشور في: (2012)

Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism.
حسب: Bachmann, M, وآخرون
منشور في: (1998)

The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma
حسب: Reinhard Dummer, وآخرون
منشور في: (2016-02-01)

Similar ligand densities required for restimulation and effector function of cytotoxic T cells.
حسب: Oxenius, A, وآخرون
منشور في: (1997)

Peripheral T cells in mice lacking p56lck do not express significant antiviral effector functions.
حسب: Molina, T, وآخرون
منشور في: (1993)

Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study.
حسب: Klimek, L, وآخرون
منشور في: (2011)

Altered peptide ligands trigger perforin- rather than Fas-dependent cell lysis.
حسب: Bachmann, M, وآخرون
منشور في: (1997)

Tumor cell plasticity and angiogenesis in human melanomas.
حسب: Daniela Mihic-Probst, وآخرون
منشور في: (2012-01-01)

pDC Activation by TLR7/8 Ligand CL097 Compared to TLR7 Ligand IMQ or TLR9 Ligand CpG
حسب: Jing Wu, وآخرون
منشور في: (2019-01-01)

Limited in vivo reactivity of polyclonal effector cytotoxic T cells towards altered peptide ligands.
حسب: Bättig, P, وآخرون
منشور في: (2005)

The C-terminal extension landscape of naturally presented HLA-I ligands
حسب: Guillaume, P, وآخرون
منشور في: (2018)

Nectin Family Ligands Trigger Immune Effector Functions in Health and Autoimmunity
حسب: Doryssa Hermans, وآخرون
منشور في: (2023-03-01)

Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with TwoState-of-the-Art Techniques
حسب: Nicola L. Schoenewolf, وآخرون
منشور في: (2012-06-01)

Maintenance of homeostasis by TLR4 ligands
حسب: Masataka Oda, وآخرون
منشور في: (2024-04-01)

T cell responses are governed by avidity and co-stimulatory thresholds.
حسب: Bachmann, M, وآخرون
منشور في: (1996)

The Ligands for Human IgG and Their Effector Functions
حسب: Steven W. de Taeye, وآخرون
منشور في: (2019-04-01)

Low Avidity T Cells Do Not Hinder High Avidity T Cell Responses Against Melanoma
حسب: Kalliopi Ioannidou, وآخرون
منشور في: (2019-09-01)

CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
حسب: Speiser, D, وآخرون
منشور في: (1999)

Fonsecaeapedrosoi Conidia and Hyphae Activate Neutrophils Distinctly: Requirement of TLR-2 and TLR-4 in Neutrophil Effector Functions
حسب: Leandro Carvalho Dantas Breda, وآخرون
منشور في: (2020-10-01)

Evolving impact of long-term survival results on metastatic melanoma treatment
حسب: Olivier Michielin, وآخرون
منشور في: (2020-10-01)

Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients.
حسب: Alessandra Curioni-Fontecedro, وآخرون
منشور في: (2011-01-01)

Toll-Like Receptor Ligand-Induced Liver Injury in D-Galactosamine-Sensitized Mice: Differences between TLR7/8 and TLR9 Ligands, Cytokine Patterns, and Cross-Tolerance Induction by TLR2 Ligand Pretreatment
حسب: Reiko Seki
منشور في: (2017-01-01)

Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery
حسب: Kelsey A. Gregg, وآخرون
منشور في: (2017-07-01)

TLR ligands induce antiviral responses in chicken macrophages.
حسب: Neda Barjesteh, وآخرون
منشور في: (2014-01-01)

Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients
حسب: Ken Kudura, وآخرون
منشور في: (2021-05-01)

T-cell-independent antiviral B cell responses in CD45-deficient mice.
حسب: Bachmann, M, وآخرون
منشور في: (1997)

A Highly Sensitive Cell-Based TLR Reporter Platform for the Specific Detection of Bacterial TLR Ligands
حسب: Katharina Radakovics, وآخرون
منشور في: (2022-01-01)

Combinations of TLR Ligands: A Promising Approach in Cancer Immunotherapy
حسب: Saskia Stier, وآخرون
منشور في: (2013-01-01)

Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma
حسب: Marina Tusup, وآخرون
منشور في: (2021-01-01)

Combined TLR7/8 and TLR9 ligands potentiate the activity of a Schistosoma japonicum DNA vaccine.
حسب: Xuefeng Wang, وآخرون
منشور في: (2013-01-01)

Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding.
حسب: Joseph A Newman, وآخرون
منشور في: (2016-01-01)

Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?
حسب: Joanna Mangana, وآخرون
منشور في: (2015-01-01)

SR-A/MARCO-mediated ligand delivery enhances intracellular TLR and NLR function, but ligand scavenging from cell surface limits TLR4 response to pathogens.
حسب: Mukhopadhyay, S, وآخرون
منشور في: (2011)

CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond
حسب: Nathan Karin
منشور في: (2020-05-01)

Very Late Antigen-1 marks functional tumor-resident CD8 T cells and correlates with survival of melanoma patients
حسب: Timothy Murray, وآخرون
منشور في: (2016-12-01)

TLR-Agonist Mediated Enhancement of Antibody-Dependent Effector Functions as Strategy For an HIV-1 Cure
حسب: Caroline Thue Hvilsom, وآخرون
منشور في: (2021-09-01)

Prediction of cross-recognition of peptide-HLA A2 by Melan-A-specific cytotoxic T lymphocytes using three-dimensional quantitative structure-activity relationships.
حسب: Theres Fagerberg, وآخرون
منشور في: (2013-01-01)